{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:56:12Z","timestamp":1767830172028,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.biologicals.2012.11.003","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T03:33:12Z","timestamp":1356147192000},"page":"98-103","source":"Crossref","is-referenced-by-count":6,"title":["Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix"],"prefix":"10.1016","volume":"41","author":[{"given":"Jarad M.","family":"Schiffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Maniatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana","family":"Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelene","family":"Steward-Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence T.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip R.","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne V.","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.biologicals.2012.11.003_bib1","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.300.13.1532","article-title":"Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months","volume":"300","author":"Marano","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.biologicals.2012.11.003_bib2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen","volume":"8","author":"Quinn","year":"2002","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.biologicals.2012.11.003_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jim.2011.12.002","article-title":"Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG","volume":"376","author":"Semenova","year":"2012","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.biologicals.2012.11.003_bib4","article-title":"Blood collection on filter paper for neonatal screening programs","author":"Hannon","year":"2007"},{"key":"10.1016\/j.biologicals.2012.11.003_bib5","doi-asserted-by":"crossref","first-page":"1631S","DOI":"10.1093\/jn\/131.5.1631S","article-title":"Use of filter paper for the collection and analysis of human whole blood specimens","volume":"131","author":"Mei","year":"2001","journal-title":"Journal of Nutrition"},{"key":"10.1016\/j.biologicals.2012.11.003_bib6","series-title":"10th conference on retroviruses and opportunistic infections, 2002 Feb, Boston, MA, and HIV diagnostics: new developments and challenges, 2005 Feb, Orlando, FL","article-title":"Use of dried blood spots in a less-sensitive HIV enzyme immunoassay to test for HIV incidence [poster]","author":"Schiffer","year":"2005"},{"issue":"3","key":"10.1016\/j.biologicals.2012.11.003_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1590\/S0036-46652008000300004","article-title":"Evaluation of the human immunodeficiency virus type 1 and 2 antibodies detection in dried whole blood spots (DBS) samples","volume":"50","author":"Castro","year":"2008","journal-title":"Revista do Instituto de Medicina Tropical de Sao Paulo"},{"issue":"4","key":"10.1016\/j.biologicals.2012.11.003_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1353\/dem.2007.0038","article-title":"What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research","volume":"44","author":"McDade","year":"2007","journal-title":"Demography"},{"key":"10.1016\/j.biologicals.2012.11.003_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1475-2875-7-195","article-title":"Dried blood spots as a source of anti-malarial antibodies for epidemiological studies","volume":"7","author":"Corran","year":"2008","journal-title":"Malaria Journal"},{"issue":"3","key":"10.1016\/j.biologicals.2012.11.003_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2893.2008.01061.x","article-title":"Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service","volume":"16","author":"Craine","year":"2009","journal-title":"Journal of Viral Hepatitis"},{"issue":"14","key":"10.1016\/j.biologicals.2012.11.003_bib11","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4155\/bio.11.128","article-title":"Investigations into the environmental conditions experienced during ambient sample transport: impact to dried blood spot sample shipments","volume":"3","author":"Bowen","year":"2011","journal-title":"Bioanalysis"},{"issue":"10","key":"10.1016\/j.biologicals.2012.11.003_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerging Infectious Diseases"},{"issue":"6","key":"10.1016\/j.biologicals.2012.11.003_bib13","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1128\/JCM.00229-11","article-title":"Sensitivity and specificity of serologic assays for the detection of human infection with 2009 pandemic H1N1 virus in U.S. populations","volume":"49","author":"Veguilla","year":"2011","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.biologicals.2012.11.003_bib14","series-title":"Guidance for industry: bioanalytical method validation","author":"Food and Drug Administration","year":"2001"},{"issue":"5","key":"10.1016\/j.biologicals.2012.11.003_bib15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/CDLI.11.5.919-923.2004","article-title":"Mass value assignment of total and subclass immunoglobulin G in a human standard reference serum","volume":"11","author":"Semenova","year":"2004","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"10.1016\/j.biologicals.2012.11.003_bib16","unstructured":"Centers for Disease Control and Prevention and Association of Public Health Laboratories. Newborn screening quality assurance program 2011 Annual summary report; 2012, http:\/\/www.cdc.gov\/labstandards\/pdf\/nsqap\/nsqap_summaryreport_2012.pdf."},{"issue":"6","key":"10.1016\/j.biologicals.2012.11.003_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.biologicals.2010.09.001","article-title":"A\u00a0two stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials","volume":"38","author":"Soroka","year":"2010","journal-title":"Biologicals"},{"issue":"2","key":"10.1016\/j.biologicals.2012.11.003_bib18","first-page":"55","article-title":"Coefficient of accuracy and concordance correlation coefficient: new statistics for methods comparison","volume":"52","author":"Lin","year":"1998","journal-title":"PDA Journal of Pharmaceutical Science and Technology"},{"key":"10.1016\/j.biologicals.2012.11.003_bib19","unstructured":"McBride GB. A proposal for strength-of-agreement criteria for Lin's concordance correlation coefficient, NIWA Client Report; 2005, HAM2005-062."}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105612001807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105612001807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T09:54:38Z","timestamp":1595152478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105612001807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1045105612001807"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2012.11.003","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}